Aldeyra Therapeutics, Inc.·4

Mar 7, 5:30 PM ET

McMullin David 4

4 · Aldeyra Therapeutics, Inc. · Filed Mar 7, 2019

Insider Transaction Report

Form 4
Period: 2019-03-05
McMullin David
SVP Corp. Dev. & Strategy
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2019-03-05+45,21245,212 total
    Exercise: $8.05Exp: 2029-03-04Common Stock (45,212 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION